Free Trial

Kyndryl (KD) Financials

Kyndryl logo
$39.14 +0.27 (+0.69%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$39.01 -0.13 (-0.33%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Kyndryl

Annual Income Statements for Kyndryl

This table shows Kyndryl's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2020 2019
Period end date 3/31/2024 3/31/2023 12/31/2021 12/31/2020 12/31/2019
Net Income / (Loss) Attributable to Common Shareholders
-340 -1,374 -2,304 -2,007 -943
Consolidated Net Income / (Loss)
-340 -1,374 -2,304 -2,007 -943
Net Income / (Loss) Continuing Operations
-340 -1,375 -2,305 -2,007 -943
Total Pre-Tax Income
-168 -851 -1,903 -1,760 -579
Total Operating Income
91 -756 -1,800 -1,697 -503
Total Gross Profit
2,863 2,528 2,107 2,215 2,597
Total Revenue
16,052 17,026 18,657 19,352 20,279
Operating Revenue
16,052 17,026 18,657 19,352 20,279
Total Cost of Revenue
13,189 14,498 16,550 17,137 17,682
Operating Cost of Revenue
13,189 14,498 16,550 17,137 17,682
Total Operating Expenses
2,772 3,284 3,907 3,912 3,100
Selling, General & Admin Expense
2,773 2,914 2,776 2,948 2,970
Other Operating Expenses / (Income)
45 106 35 943 -29
Impairment Charge
0.00 0.00 469 0.00 0.00
Restructuring Charge
-46 264 627 21 159
Total Other Income / (Expense), net
-260 -94 -103 -63 -76
Interest Expense
260 94 103 63 76
Income Tax Expense
172 524 402 247 364
Basic Earnings per Share
($1.48) ($6.06) ($10.28) ($8.96) ($4.21)
Weighted Average Basic Shares Outstanding
229.20M 226.70M 224.10M 224.10M 224.10M
Diluted Earnings per Share
($1.48) ($6.06) ($10.28) ($8.96) ($4.21)
Weighted Average Diluted Shares Outstanding
229.20M 226.70M 224.10M 224.10M 224.10M
Weighted Average Basic & Diluted Shares Outstanding
230.51M 227.84M 224.54M - -
Cash Dividends to Common per Share
$0.00 $0.00 $0.00 $0.00 $0.00

Quarterly Income Statements for Kyndryl

This table shows Kyndryl's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Net Income / (Loss) Attributable to Common Shareholders
215 -43 11 -45 -12 -142 -141 -737 -106 -281 -250
Consolidated Net Income / (Loss)
215 -43 11 -45 -12 -142 -141 -737 -106 -281 -250
Net Income / (Loss) Continuing Operations
215 -43 11 -45 -12 -142 -141 -739 -106 -280 -250
Total Pre-Tax Income
258 -5.00 64 -3.00 53 -109 -109 -289 -138 -219 -205
Total Operating Income
299 20 92 89 103 -39 -23 -270 -102 -201 -183
Total Gross Profit
763 750 805 716 752 651 744 644 707 566 611
Total Revenue
3,744 3,774 3,739 3,850 3,936 4,073 4,193 4,256 4,303 4,179 4,288
Operating Revenue
3,744 3,774 3,739 3,850 3,936 4,073 4,193 4,256 4,303 4,179 4,288
Total Cost of Revenue
2,981 3,024 2,934 3,134 3,184 3,422 3,449 3,612 3,596 3,613 3,677
Operating Cost of Revenue
2,981 3,024 2,934 3,134 3,184 3,422 3,449 3,612 3,596 3,613 3,677
Total Operating Expenses
464 730 713 627 649 690 767 914 809 767 794
Selling, General & Admin Expense
647 647 657 714 705 634 720 783 731 706 694
Other Operating Expenses / (Income)
-35 83 36 -28 21 8.00 5.00 86 30 -7.00 -3.00
Restructuring Charge
-148 0.00 20 -59 -77 48 42 45 48 68 103
Total Other Income / (Expense), net
-41 -25 -28 -92 -50 -70 -87 -14 -37 -19 -24
Interest Expense
41 25 28 92 50 70 87 14 37 19 24
Income Tax Expense
43 38 53 42 65 33 32 450 -32 61 45
Basic Earnings per Share
$0.93 ($0.19) $0.05 ($0.19) ($0.05) ($0.62) ($0.62) ($3.24) ($0.47) ($1.24) ($1.11)
Weighted Average Basic Shares Outstanding
232.20M 231.60M 230.50M 229.20M 229.60M 229.10M 227.90M 226.70M 227M 226.80M 225.30M
Diluted Earnings per Share
$0.89 ($0.19) $0.05 ($0.19) ($0.05) ($0.62) ($0.62) ($3.24) ($0.47) ($1.24) ($1.11)
Weighted Average Diluted Shares Outstanding
240.70M 231.60M 235.80M 229.20M 229.60M 229.10M 227.90M 226.70M 227M 226.80M 225.30M
Weighted Average Basic & Diluted Shares Outstanding
232.69M 232.27M 231.21M 230.51M 230.10M 229.46M 228.89M 227.84M 227.51M 226.79M 226.76M
Cash Dividends to Common per Share
$0.00 $0.00 $0.00 - $0.00 $0.00 $0.00 - $0.00 $0.00 $0.00

Annual Cash Flow Statements for Kyndryl

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2020 2019
Period end date 3/31/2024 3/31/2023 12/31/2021 12/31/2020 12/31/2019
Net Change in Cash & Equivalents
-306 -294 2,203 -13 5.00
Net Cash From Operating Activities
454 781 -119 628 1,134
Net Cash From Continuing Operating Activities
454 784 -117 631 1,133
Net Income / (Loss) Continuing Operations
-340 -1,374 -2,304 -2,007 -943
Consolidated Net Income / (Loss)
-340 -1,374 -2,304 -2,007 -943
Depreciation Expense
1,153 1,328 1,627 1,869 1,898
Amortization Expense
1,817 1,717 1,878 2,091 2,137
Non-Cash Adjustments To Reconcile Net Income
138 119 551 68 52
Changes in Operating Assets and Liabilities, net
-2,314 -1,006 -1,869 -1,390 -2,011
Net Cash From Investing Activities
-553 -835 -572 -953 -1,128
Net Cash From Continuing Investing Activities
-553 -835 -572 -953 -1,129
Purchase of Property, Plant & Equipment
-651 -865 -752 -1,036 -1,190
Sale of Property, Plant & Equipment
138 23 194 84 63
Other Investing Activities, net
-40 7.00 -14 -1.00 -2.00
Net Cash From Financing Activities
-170 -141 2,915 312 0.00
Net Cash From Continuing Financing Activities
-170 -141 2,916 311 0.00
Repayment of Debt
-642 -122 -91 -66 -18
Issuance of Debt
494 0.00 3,038 0.00 0.00
Other Financing Activities, net
-22 -19 -31 377 18
Effect of Exchange Rate Changes
-37 -100 -22 - -1.00
Cash Interest Paid
118 98 2.00 0.00 0.00
Cash Income Taxes Paid
191 167 12 0.00 0.00

Quarterly Cash Flow Statements for Kyndryl

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Net Change in Cash & Equivalents
175 57 -281 -137 279 -109 -339 -156 115 13 -266
Net Cash From Operating Activities
260 149 -48 145 436 46 -173 12 278 387 104
Net Cash From Continuing Operating Activities
259 148 -47 146 435 46 -173 15 276 389 104
Net Income / (Loss) Continuing Operations
215 -43 11 -45 -12 -142 -141 -737 -106 -281 -250
Consolidated Net Income / (Loss)
215 -43 11 -45 -12 -142 -141 -737 -106 -281 -250
Depreciation Expense
261 233 197 263 286 303 301 362 326 327 313
Amortization Expense
442 445 424 430 460 456 471 435 451 413 418
Non-Cash Adjustments To Reconcile Net Income
-65 -16 51 72 -4.00 19 51 55 -11 47 28
Changes in Operating Assets and Liabilities, net
-594 -471 -730 -574 -295 -590 -855 -100 -384 -117 -405
Net Cash From Investing Activities
42 -75 -166 -203 -142 -95 -113 -136 -183 -298 -218
Net Cash From Continuing Investing Activities
41 -75 -166 -203 -141 -96 -113 -136 -183 -297 -219
Purchase of Property, Plant & Equipment
-109 -134 -122 -202 -174 -175 -100 -154 -245 -253 -213
Sale of Property, Plant & Equipment
16 30 24 4.00 15 113 6.00 3.00 10 3.00 7.00
Other Investing Activities, net
88 29 -22 -5.00 18 -34 -19 15 52 -47 -13
Net Cash From Financing Activities
-71 -50 -51 -47 -43 -42 -38 -41 -31 -28 -41
Net Cash From Continuing Financing Activities
-70 -51 -51 -47 -43 -42 -38 -41 -31 -28 -41
Repayment of Debt
-32 -34 -44 -538 -36 -37 -31 -39 -27 -28 -28
Other Financing Activities, net
-8.00 -17 -7.00 -3.00 -7.00 -5.00 -7.00 -2.00 -4.00 - -13
Effect of Exchange Rate Changes
-56 34 -17 -32 28 -18 -15 9.00 51 -49 -111
Cash Interest Paid
40 20 40 10 49 13 46 9.00 55 -4.00 38
Cash Income Taxes Paid
34 35 54 51 52 23 65 58 72 29 8.00

Annual Balance Sheets for Kyndryl

This table presents Kyndryl's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2020
Period end date 3/31/2024 3/31/2023 3/31/2022 12/31/2020
Total Assets
10,590 11,464 13,442 11,205
Total Current Assets
4,747 4,963 6,092 2,843
Cash & Equivalents
1,553 1,847 2,134 24
Restricted Cash
1.00 12 20 14
Accounts Receivable
1,599 1,523 2,271 1,444
Prepaid Expenses
514 510 525 157
Other Current Assets
1,081 1,070 1,143 1,205
Plant, Property, & Equipment, net
2,674 2,779 2,834 3,991
Total Noncurrent Assets
3,169 3,722 4,515 4,372
Goodwill
805 812 823 1,230
Intangible Assets
188 171 145 60
Noncurrent Deferred & Refundable Income Taxes
220 248 555 424
Employee Benefit Assets
105 94 61 1.00
Other Noncurrent Operating Assets
1,851 2,397 2,931 2,657
Total Liabilities & Shareholders' Equity
10,590 11,464 13,442 11,205
Total Liabilities
9,468 10,002 10,730 6,274
Total Current Liabilities
4,589 4,868 5,058 3,910
Short-Term Debt
126 110 96 69
Accounts Payable
1,408 1,774 1,555 919
Accrued Expenses
1,008 970 1,358 1,386
Current Deferred Revenue
825 820 882 854
Current Deferred & Payable Income Tax Liabilities
327 - - 0.00
Current Employee Benefit Liabilities
609 533 509 350
Other Current Liabilities
285 316 374 333
Total Noncurrent Liabilities
4,880 5,134 5,672 2,365
Long-Term Debt
3,112 3,111 3,127 140
Noncurrent Deferred Revenue
314 362 452 543
Noncurrent Employee Benefit Liabilities
500 504 716 550
Other Noncurrent Operating Liabilities
954 1,157 1,377 1,132
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,122 1,462 2,711 4,931
Total Preferred & Common Equity
1,015 1,365 2,618 4,873
Total Common Equity
1,015 1,365 2,617 4,872
Common Stock
4,524 4,428 4,315 0.00
Retained Earnings
-2,319 -1,978 -605 0.00
Treasury Stock
-45 -23 -4.00 0.00
Accumulated Other Comprehensive Income / (Loss)
-1,145 -1,062 -1,089 -1,100
Noncontrolling Interest
107 97 94 58

Quarterly Balance Sheets for Kyndryl

This table presents Kyndryl's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 12/31/2021
Total Assets
9,925 10,396 10,163 10,969 10,602 10,986 11,851 11,629 12,304 13,213
Total Current Assets
4,297 4,387 4,355 4,851 4,593 4,653 4,967 4,964 5,404 5,777
Cash & Equivalents
1,501 1,325 1,269 1,688 1,408 1,507 2,002 1,888 1,871 2,223
Restricted Cash
5.00 5.00 5.00 2.00 3.00 14 14 12 17 17
Accounts Receivable
1,374 1,441 1,440 1,658 1,663 1,490 1,539 1,578 1,902 2,279
Prepaid Expenses
529 623 613 578 566 567 486 512 522 337
Other Current Assets
889 994 1,029 924 952 1,075 927 973 1,092 920
Plant, Property, & Equipment, net
2,490 2,735 2,690 2,806 2,646 2,750 2,762 2,592 2,651 2,923
Total Noncurrent Assets
3,140 3,273 3,117 3,313 3,364 3,583 4,122 4,072 4,250 4,512
Goodwill
787 790 786 809 806 807 812 811 815 732
Intangible Assets
219 227 222 192 188 187 158 139 154 36
Noncurrent Deferred & Refundable Income Taxes
184 209 207 208 186 190 478 481 525 675
Employee Benefit Assets
130 123 109 105 97 100 58 54 58 58
Other Noncurrent Operating Assets
1,820 1,924 1,793 1,999 2,087 2,299 2,616 2,587 2,698 3,011
Total Liabilities & Shareholders' Equity
9,925 10,396 10,163 10,969 10,602 10,986 11,851 11,629 12,304 13,213
Total Liabilities
8,721 9,224 9,062 9,676 9,489 9,648 9,920 9,882 10,093 10,446
Total Current Liabilities
3,935 4,249 4,231 5,152 4,485 4,591 4,607 4,579 4,609 4,457
Short-Term Debt
129 135 130 628 121 134 103 97 93 105
Accounts Payable
1,147 1,240 1,337 1,477 1,246 1,626 1,719 1,594 1,486 1,140
Accrued Expenses
867 904 969 1,107 1,137 907 1,006 1,042 1,129 1,242
Current Deferred Revenue
782 856 805 793 790 785 817 726 774 872
Current Deferred & Payable Income Tax Liabilities
259 - - 332 - 359 245 - 274 357
Current Employee Benefit Liabilities
492 538 414 559 609 473 388 534 503 381
Other Current Liabilities
259 278 271 257 274 307 329 322 350 360
Total Noncurrent Liabilities
4,786 4,975 4,830 4,523 5,003 5,057 5,313 5,303 5,485 5,988
Long-Term Debt
3,072 3,106 3,109 2,629 3,123 3,149 3,097 3,101 3,107 3,128
Noncurrent Deferred Revenue
328 344 325 326 316 334 377 373 413 475
Noncurrent Employee Benefit Liabilities
475 510 492 493 481 501 660 625 671 856
Other Noncurrent Operating Liabilities
911 1,015 904 1,075 1,083 1,073 1,179 1,204 1,294 1,529
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,204 1,172 1,101 1,293 1,113 1,338 1,930 1,746 2,211 2,767
Total Preferred & Common Equity
1,094 1,065 996 1,189 1,013 1,240 1,832 1,650 2,117 2,765
Total Common Equity
1,094 1,065 996 1,190 1,012 1,239 1,832 1,650 2,116 2,765
Common Stock
4,607 4,575 4,549 4,501 4,476 4,451 4,397 4,370 4,341 4,284
Retained Earnings
-2,136 -2,351 -2,308 -2,274 -2,262 -2,120 -1,241 -1,136 -855 -375
Treasury Stock
-107 -69 -53 -42 -35 -30 -21 -17 -17 -1.00
Accumulated Other Comprehensive Income / (Loss)
-1,270 -1,090 -1,192 -995 -1,167 -1,062 -1,303 -1,567 -1,353 -1,143
Noncontrolling Interest
110 107 105 104 100 99 99 96 95 3.00

Annual Metrics And Ratios for Kyndryl

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric 2024 2023 2022 2021 2020 2019
Period end date 3/31/2024 3/31/2023 12/31/2021 12/31/2021 12/31/2020 12/31/2019
Growth Metrics
- - - - - -
Revenue Growth
-5.72% -8.74% 0.00% -3.59% -4.57% 0.00%
EBITDA Growth
33.73% 34.25% 0.00% -24.66% -35.93% 0.00%
EBIT Growth
112.04% 58.00% 0.00% -6.07% -237.38% 0.00%
NOPAT Growth
112.04% 58.00% 0.00% -6.07% -237.38% 0.00%
Net Income Growth
75.25% 40.36% 0.00% -14.80% -112.83% 0.00%
EPS Growth
75.58% 41.05% 0.00% -14.73% -112.83% 0.00%
Operating Cash Flow Growth
-41.87% 756.30% 0.00% -118.95% -44.62% 0.00%
Free Cash Flow Firm Growth
-81.96% 133.60% -1,644.58% 101.32% 0.00% 0.00%
Invested Capital Growth
-0.50% -25.39% 0.59% -26.32% 0.00% 0.00%
Revenue Q/Q Growth
-2.47% -2.94% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
9.09% -2.14% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
133.96% 9.68% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
133.96% 9.68% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
67.05% -21.49% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
67.33% -20.72% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
41.43% 77.10% -114.60% 71.67% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
13.60% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-1.85% -9.47% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
17.84% 14.85% 11.29% 11.29% 11.45% 12.81%
EBITDA Margin
19.07% 13.44% 9.14% 9.14% 11.69% 17.42%
Operating Margin
0.57% -4.44% -9.65% -9.65% -8.77% -2.48%
EBIT Margin
0.57% -4.44% -9.65% -9.65% -8.77% -2.48%
Profit (Net Income) Margin
-2.12% -8.07% -12.35% -12.35% -10.37% -4.65%
Tax Burden Percent
202.38% 161.46% 121.07% 121.07% 114.03% 162.87%
Interest Burden Percent
-184.62% 112.57% 105.72% 105.72% 103.71% 115.11%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
2.26% -16.03% -33.42% -28.44% -46.57% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-24.26% -85.59% -134.68% -207.97% -1,004.58% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-28.58% -49.82% -53.16% -31.42% -34.84% 0.00%
Return on Equity (ROE)
-26.32% -65.85% -86.58% -59.86% -81.40% 0.00%
Cash Return on Invested Capital (CROIC)
2.76% 13.05% -34.01% 1.87% -246.57% 0.00%
Operating Return on Assets (OROA)
0.83% -6.07% -13.39% -14.74% -15.15% 0.00%
Return on Assets (ROA)
-3.08% -11.03% -17.14% -18.87% -17.91% 0.00%
Return on Common Equity (ROCE)
-24.24% -62.84% -83.58% -59.39% -80.43% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-33.50% -100.66% -88.01% -83.33% -41.19% 0.00%
Net Operating Profit after Tax (NOPAT)
64 -529 -1,260 -1,260 -1,188 -352
NOPAT Margin
0.40% -3.11% -6.75% -6.75% -6.14% -1.74%
Net Nonoperating Expense Percent (NNEP)
26.52% 69.56% 101.26% 179.54% 958.01% 0.00%
Cost of Revenue to Revenue
82.16% 85.15% 88.71% 88.71% 88.55% 87.19%
SG&A Expenses to Revenue
17.28% 17.12% 14.88% 14.88% 15.23% 14.65%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
17.27% 19.29% 20.94% 20.94% 20.22% 15.29%
Earnings before Interest and Taxes (EBIT)
91 -756 -1,800 -1,800 -1,697 -503
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,061 2,289 1,705 1,705 2,263 3,532
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
4.93 2.46 1.55 1.47 0.00 0.00
Price to Tangible Book Value (P/TBV)
227.59 8.79 2.46 2.03 0.00 0.00
Price to Revenue (P/Rev)
0.31 0.20 0.22 0.22 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.42 1.71 1.38 1.34 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.42 0.28 0.28 0.27 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
2.22 2.10 3.06 2.96 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
74.70 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
106.72 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
14.97 6.17 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
87.49 11.18 0.00 60.87 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
2.89 2.20 1.19 1.17 0.04 0.00
Long-Term Debt to Equity
2.77 2.13 1.15 1.13 0.03 0.00
Financial Leverage
1.18 0.58 0.39 0.15 0.03 0.00
Leverage Ratio
8.53 5.97 4.96 3.17 2.27 0.00
Compound Leverage Factor
-15.76 6.72 5.24 3.35 2.36 0.00
Debt to Total Capital
74.27% 68.78% 54.31% 53.88% 4.07% 0.00%
Short-Term Debt to Total Capital
2.89% 2.35% 1.62% 1.75% 1.34% 0.00%
Long-Term Debt to Total Capital
71.38% 66.43% 52.70% 52.13% 2.72% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.45% 2.07% 1.58% 0.05% 1.13% 0.00%
Common Equity to Total Capital
23.28% 29.15% 44.10% 46.08% 94.79% 0.00%
Debt to EBITDA
1.06 1.41 1.89 1.90 0.09 0.00
Net Debt to EBITDA
0.55 0.60 0.63 0.58 0.08 0.00
Long-Term Debt to EBITDA
1.02 1.36 1.83 1.83 0.06 0.00
Debt to NOPAT
50.83 -6.09 -2.56 -2.57 -0.18 0.00
Net Debt to NOPAT
26.44 -2.57 -0.85 -0.79 -0.14 0.00
Long-Term Debt to NOPAT
48.85 -5.88 -2.48 -2.48 -0.12 0.00
Altman Z-Score
1.57 1.24 1.20 1.28 0.00 0.00
Noncontrolling Interest Sharing Ratio
7.89% 4.58% 3.47% 0.79% 1.20% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
1.03 1.02 1.20 1.30 0.73 0.00
Quick Ratio
0.69 0.69 0.87 1.01 0.38 0.00
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
78 431 -1,282 83 -6,290 0.00
Operating Cash Flow to CapEx
88.50% 92.76% -21.33% -21.33% 65.97% 100.62%
Free Cash Flow to Firm to Interest Expense
0.30 4.58 -12.45 0.81 -99.84 0.00
Operating Cash Flow to Interest Expense
1.75 8.31 -1.16 -1.16 9.97 14.92
Operating Cash Flow Less CapEx to Interest Expense
-0.23 -0.65 -6.57 -6.57 -5.14 0.09
Efficiency Ratios
- - - - - -
Asset Turnover
1.46 1.37 1.39 1.53 1.73 0.00
Accounts Receivable Turnover
10.28 8.98 8.22 10.02 13.40 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
5.89 6.07 6.58 5.40 4.85 0.00
Accounts Payable Turnover
8.29 8.71 10.64 16.08 18.65 0.00
Days Sales Outstanding (DSO)
35.50 40.67 44.43 36.42 27.24 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
44.03 41.91 34.29 22.71 19.57 0.00
Cash Conversion Cycle (CCC)
-8.54 -1.24 10.13 13.71 7.66 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
2,807 2,821 3,781 3,759 5,102 0.00
Invested Capital Turnover
5.70 5.16 4.95 4.21 7.59 0.00
Increase / (Decrease) in Invested Capital
-14 -960 22 -1,343 5,102 0.00
Enterprise Value (EV)
6,798 4,817 5,220 5,052 0.00 0.00
Market Capitalization
5,007 3,358 4,057 4,056 0.00 0.00
Book Value per Share
$4.41 $6.00 $11.68 $12.34 $21.74 $0.00
Tangible Book Value per Share
$0.10 $1.68 $7.36 $8.91 $15.98 $0.00
Total Capital
4,360 4,683 5,934 6,000 5,140 0.00
Total Debt
3,238 3,221 3,223 3,233 209 0.00
Total Long-Term Debt
3,112 3,111 3,127 3,128 140 0.00
Net Debt
1,684 1,362 1,069 993 171 0.00
Capital Expenditures (CapEx)
513 842 558 558 952 1,127
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,270 -1,654 -1,024 -815 -1,036 0.00
Debt-free Net Working Capital (DFNWC)
284 205 1,130 1,425 -998 0.00
Net Working Capital (NWC)
158 95 1,034 1,320 -1,067 0.00
Net Nonoperating Expense (NNE)
404 845 1,044 1,044 819 591
Net Nonoperating Obligations (NNO)
1,685 1,359 1,070 992 171 0.00
Total Depreciation and Amortization (D&A)
2,970 3,045 3,505 3,505 3,960 4,035
Debt-free, Cash-free Net Working Capital to Revenue
-7.91% -9.71% -5.49% -4.37% -5.35% 0.00%
Debt-free Net Working Capital to Revenue
1.77% 1.20% 6.06% 7.64% -5.16% 0.00%
Net Working Capital to Revenue
0.98% 0.56% 5.54% 7.08% -5.51% 0.00%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
($1.48) ($6.06) ($10.35) ($10.35) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
229.20M 226.70M 224.10M 224.10M 0.00 0.00
Adjusted Diluted Earnings per Share
($1.48) ($6.06) ($10.35) ($10.35) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
229.20M 226.70M 224.10M 224.10M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
230.51M 227.84M 224.54M 224.54M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
32 -344 -493 -493 -1,173 -241
Normalized NOPAT Margin
0.20% -2.02% -2.64% -2.64% -6.06% -1.19%
Pre Tax Income Margin
-1.05% -5.00% -10.20% -10.20% -9.09% -2.86%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.35 -8.04 -17.48 -17.48 -26.94 -6.62
NOPAT to Interest Expense
0.25 -5.63 -12.23 -12.23 -18.86 -4.63
EBIT Less CapEx to Interest Expense
-1.62 -17.00 -22.89 -22.89 -42.05 -21.45
NOPAT Less CapEx to Interest Expense
-1.73 -14.59 -17.65 -17.65 -33.97 -19.46
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Kyndryl

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.88% -7.34% -10.83% -9.54% -8.53% -2.54% -2.22% -10.79% -5.55% -8.74% -9.75%
EBITDA Growth
18.02% -3.06% -4.81% 48.39% 25.78% 33.58% 36.68% -8.67% 530.84% 35.77% -12.18%
EBIT Growth
190.29% 151.28% 500.00% 132.96% 200.98% 80.60% 87.43% 23.08% 85.47% 55.23% 38.59%
NOPAT Growth
1,168.43% 151.28% 198.21% 132.96% 67.34% 80.60% 87.43% 23.08% 85.47% 55.23% 38.59%
Net Income Growth
1,891.67% 69.72% 107.80% 93.89% 88.68% 49.47% 43.60% -49.19% 85.50% 59.28% 35.73%
EPS Growth
1,880.00% 69.35% 108.06% 94.14% 89.36% 50.00% 44.14% -47.27% 85.58% 59.74% 36.21%
Operating Cash Flow Growth
-40.37% 223.91% 72.25% 1,108.33% 56.83% -88.11% -266.35% 103.66% -54.13% 263.98% 164.60%
Free Cash Flow Firm Growth
-10.96% -277.58% -88.25% -90.10% -59.29% 102.16% 111.14% 0.00% -34.34% 0.00% 0.00%
Invested Capital Growth
1.47% 4.61% -1.03% -0.50% -8.22% -3.15% -12.01% -25.39% -17.11% 0.00% 0.00%
Revenue Q/Q Growth
-0.79% 0.94% -2.88% -2.19% -3.36% -2.86% -1.48% -1.09% 2.97% -2.54% -10.12%
EBITDA Q/Q Growth
43.55% -2.10% -8.82% -7.89% 17.92% -3.87% 42.13% -21.93% 25.23% -1.64% -5.03%
EBIT Q/Q Growth
1,395.00% -78.26% 3.37% -13.59% 364.10% -69.57% 91.48% -164.71% 49.25% -9.84% 47.86%
NOPAT Q/Q Growth
1,679.76% -11.46% -74.62% 367.14% 14.58% -69.57% 91.48% -164.71% 49.25% -9.84% 47.86%
Net Income Q/Q Growth
600.00% -490.91% 124.44% -275.00% 91.55% -0.71% 80.87% -595.28% 62.28% -12.40% 49.39%
EPS Q/Q Growth
568.42% -480.00% 126.32% -280.00% 91.94% 0.00% 80.86% -589.36% 62.10% -11.71% 49.55%
Operating Cash Flow Q/Q Growth
74.50% 410.42% -133.10% -66.74% 847.83% 126.59% -1,541.67% -95.68% -28.17% 272.12% 131.71%
Free Cash Flow Firm Q/Q Growth
269.81% -355.16% -37.34% -67.21% 238.69% -83.12% -47.22% 34.88% 117.95% 12.80% 0.00%
Invested Capital Q/Q Growth
-5.87% 0.49% 9.30% -1.85% -2.95% -4.94% 9.89% -9.47% 2.40% -13.62% -6.82%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.38% 19.87% 21.53% 18.60% 19.11% 15.98% 17.74% 15.13% 16.43% 13.54% 14.25%
EBITDA Margin
26.76% 18.50% 19.07% 20.31% 21.57% 17.68% 17.86% 12.38% 15.69% 12.90% 12.78%
Operating Margin
7.99% 0.53% 2.46% 2.31% 2.62% -0.96% -0.55% -6.34% -2.37% -4.81% -4.27%
EBIT Margin
7.99% 0.53% 2.46% 2.31% 2.62% -0.96% -0.55% -6.34% -2.37% -4.81% -4.27%
Profit (Net Income) Margin
5.74% -1.14% 0.29% -1.17% -0.30% -3.49% -3.36% -17.32% -2.46% -6.72% -5.83%
Tax Burden Percent
83.33% 860.00% 17.19% 1,500.00% -22.64% 130.28% 129.36% 255.02% 76.81% 128.31% 121.95%
Interest Burden Percent
86.29% -25.00% 69.57% -3.37% 51.46% 279.49% 473.91% 107.04% 135.29% 108.96% 112.02%
Effective Tax Rate
16.67% 0.00% 82.81% 0.00% 122.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
34.90% 1.88% 2.14% 9.23% -3.26% -3.77% -1.96% -22.90% -8.47% -39.38% -30.86%
ROIC Less NNEP Spread (ROIC-NNEP)
32.80% -1.16% 1.88% 2.18% -2.44% -11.09% -10.09% -68.03% -11.64% -61.01% -49.44%
Return on Net Nonoperating Assets (RNNOA)
42.89% -1.90% 2.88% 2.57% -2.09% -12.15% -8.74% -39.60% -5.40% -45.32% -29.34%
Return on Equity (ROE)
77.79% -0.02% 5.01% 11.80% -5.35% -15.91% -10.70% -62.50% -13.87% -84.70% -60.19%
Cash Return on Invested Capital (CROIC)
5.57% -11.69% -250.12% 2.76% 3.20% -6.94% 0.18% 13.05% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
11.55% 0.77% 3.63% 3.37% 3.77% -1.45% -0.80% -8.67% -3.32% -7.36% -6.31%
Return on Assets (ROA)
8.30% -1.66% 0.43% -1.70% -0.44% -5.28% -4.89% -23.68% -3.45% -10.29% -8.62%
Return on Common Equity (ROCE)
71.16% -0.02% 4.60% 10.87% -5.02% -14.82% -10.12% -59.64% -13.57% -80.04% -57.61%
Return on Equity Simple (ROE_SIMPLE)
12.61% -8.36% -18.88% 0.00% -86.80% -111.16% -102.02% 0.00% -61.74% -106.42% -102.27%
Net Operating Profit after Tax (NOPAT)
249 14 16 62 -23 -27 -16 -189 -71 -141 -128
NOPAT Margin
6.66% 0.37% 0.42% 1.62% -0.59% -0.67% -0.38% -4.44% -1.66% -3.37% -2.99%
Net Nonoperating Expense Percent (NNEP)
2.09% 3.04% 0.26% 7.05% -0.82% 7.33% 8.13% 45.12% 3.18% 21.63% 18.58%
Return On Investment Capital (ROIC_SIMPLE)
5.66% - - - -0.51% - - - - - -
Cost of Revenue to Revenue
79.62% 80.13% 78.47% 81.40% 80.89% 84.02% 82.26% 84.87% 83.57% 86.46% 85.75%
SG&A Expenses to Revenue
17.28% 17.14% 17.57% 18.55% 17.91% 15.57% 17.17% 18.40% 16.99% 16.89% 16.18%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
12.39% 19.34% 19.07% 16.29% 16.49% 16.94% 18.29% 21.48% 18.80% 18.35% 18.52%
Earnings before Interest and Taxes (EBIT)
299 20 92 89 103 -39 -23 -270 -102 -201 -183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,002 698 713 782 849 720 749 527 675 539 548
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.35 4.99 6.09 4.93 4.01 3.42 2.44 2.46 1.38 1.14 1.04
Price to Tangible Book Value (P/TBV)
91.32 110.69 0.00 227.59 25.23 192.02 12.35 8.79 2.93 2.68 1.91
Price to Revenue (P/Rev)
0.53 0.35 0.39 0.31 0.29 0.21 0.18 0.20 0.14 0.11 0.12
Price to Earnings (P/E)
58.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
3.39 2.38 2.65 2.42 2.25 1.83 1.58 1.71 1.22 1.07 1.02
Enterprise Value to Revenue (EV/Rev)
0.65 0.48 0.52 0.42 0.39 0.32 0.29 0.28 0.22 0.18 0.20
Enterprise Value to EBITDA (EV/EBITDA)
3.12 2.44 2.69 2.22 2.26 2.02 1.96 2.10 1.63 1.85 2.21
Enterprise Value to EBIT (EV/EBIT)
21.35 27.66 39.49 74.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
48.58 0.00 0.00 106.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
19.45 10.75 14.05 14.97 20.06 33.06 9.70 6.17 8.63 4.25 24.68
Enterprise Value to Free Cash Flow (EV/FCFF)
61.28 0.00 0.00 87.49 67.29 0.00 842.55 11.18 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.66 2.77 2.94 2.89 2.52 2.91 2.45 2.20 1.66 1.83 1.45
Long-Term Debt to Equity
2.55 2.65 2.82 2.77 2.03 2.81 2.35 2.13 1.60 1.78 1.41
Financial Leverage
1.31 1.64 1.53 1.18 0.85 1.10 0.87 0.58 0.46 0.74 0.59
Leverage Ratio
8.37 9.19 8.67 8.53 7.08 7.78 6.56 5.97 5.34 6.66 5.56
Compound Leverage Factor
7.22 -2.30 6.03 -0.29 3.64 21.73 31.10 6.39 7.22 7.26 6.23
Debt to Total Capital
72.67% 73.44% 74.63% 74.27% 71.58% 74.45% 71.05% 68.78% 62.38% 64.68% 59.14%
Short-Term Debt to Total Capital
2.93% 3.06% 3.00% 2.89% 13.80% 2.78% 2.90% 2.35% 2.01% 1.96% 1.72%
Long-Term Debt to Total Capital
69.74% 70.38% 71.64% 71.38% 57.78% 71.68% 68.15% 66.43% 60.37% 62.72% 57.42%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.50% 2.42% 2.42% 2.45% 2.29% 2.30% 2.14% 2.07% 1.93% 1.94% 1.76%
Common Equity to Total Capital
24.84% 24.13% 22.95% 23.28% 26.15% 23.23% 26.81% 29.15% 35.71% 33.37% 39.11%
Debt to EBITDA
1.01 1.08 1.07 1.06 1.14 1.21 1.32 1.41 1.37 1.81 1.96
Net Debt to EBITDA
0.54 0.64 0.65 0.55 0.55 0.69 0.71 0.60 0.51 0.73 0.81
Long-Term Debt to EBITDA
0.97 1.03 1.03 1.02 0.92 1.17 1.26 1.36 1.32 1.75 1.91
Debt to NOPAT
15.80 -14.98 -0.42 50.83 -20.32 -10.68 -7.87 -6.09 -5.46 -3.18 -2.71
Net Debt to NOPAT
8.37 -8.83 -0.25 26.44 -9.78 -6.03 -4.22 -2.57 -2.02 -1.29 -1.11
Long-Term Debt to NOPAT
15.16 -14.35 -0.40 48.85 -16.40 -10.28 -7.55 -5.88 -5.29 -3.08 -2.63
Altman Z-Score
1.92 1.52 1.66 1.57 1.50 1.51 1.46 1.38 1.49 1.49 1.54
Noncontrolling Interest Sharing Ratio
8.53% 9.10% 8.36% 7.89% 6.24% 6.89% 5.47% 4.58% 2.13% 5.50% 4.30%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.09 1.03 1.03 1.03 0.94 1.02 1.01 1.02 1.08 1.08 1.17
Quick Ratio
0.73 0.65 0.64 0.69 0.65 0.68 0.65 0.69 0.77 0.76 0.82
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
207 -122 48 76 233 69 407 771 572 -3,184 -3,651
Operating Cash Flow to CapEx
279.57% 143.27% -48.98% 73.23% 274.21% 74.19% -184.04% 7.95% 118.30% 154.80% 50.49%
Free Cash Flow to Firm to Interest Expense
5.05 -4.88 1.71 0.83 4.65 0.98 4.68 55.07 15.45 -167.56 -152.13
Operating Cash Flow to Interest Expense
6.34 5.96 -1.71 1.58 8.72 0.66 -1.99 0.86 7.51 20.37 4.33
Operating Cash Flow Less CapEx to Interest Expense
4.07 1.80 -5.21 -0.58 5.54 -0.23 -3.07 -9.93 1.16 7.21 -4.25
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.45 1.46 1.48 1.46 1.44 1.51 1.45 1.37 1.40 1.53 1.48
Accounts Receivable Turnover
9.97 9.86 10.65 10.28 10.30 10.38 9.98 8.98 9.19 11.28 9.57
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
5.71 5.69 5.73 5.89 5.91 6.42 6.27 6.07 6.17 6.87 6.86
Accounts Payable Turnover
9.20 9.88 8.55 8.29 8.55 9.91 9.17 8.71 10.64 9.79 10.81
Days Sales Outstanding (DSO)
36.63 37.03 34.28 35.50 35.45 35.16 36.56 40.67 39.72 32.37 38.16
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
39.67 36.96 42.67 44.03 42.68 36.81 39.80 41.91 34.32 37.28 33.76
Cash Conversion Cycle (CCC)
-3.04 0.07 -8.38 -8.54 -7.23 -1.66 -3.24 -1.24 5.41 -4.91 4.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,902 3,083 3,068 2,807 2,860 2,947 3,100 2,821 3,116 3,043 3,523
Invested Capital Turnover
5.24 5.07 5.06 5.70 5.51 5.62 5.11 5.16 5.10 11.70 10.33
Increase / (Decrease) in Invested Capital
42 136 -32 -14 -256 -96 -423 -960 -643 3,043 3,523
Enterprise Value (EV)
9,842 7,331 8,135 6,798 6,439 5,389 4,887 4,817 3,805 3,269 3,603
Market Capitalization
8,037 5,313 6,065 5,007 4,768 3,456 3,026 3,358 2,522 1,875 2,196
Book Value per Share
$4.71 $4.61 $4.32 $4.41 $5.19 $4.42 $5.44 $6.00 $8.08 $7.28 $9.42
Tangible Book Value per Share
$0.38 $0.21 ($0.05) $0.10 $0.82 $0.08 $1.08 $1.68 $3.80 $3.09 $5.11
Total Capital
4,405 4,413 4,340 4,360 4,550 4,357 4,621 4,683 5,130 4,944 5,411
Total Debt
3,201 3,241 3,239 3,238 3,257 3,244 3,283 3,221 3,200 3,198 3,200
Total Long-Term Debt
3,072 3,106 3,109 3,112 2,629 3,123 3,149 3,111 3,097 3,101 3,107
Net Debt
1,695 1,911 1,965 1,684 1,567 1,833 1,762 1,362 1,184 1,298 1,312
Capital Expenditures (CapEx)
93 104 98 198 159 62 94 151 235 250 206
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,015 -1,057 -1,020 -1,270 -1,363 -1,182 -1,325 -1,654 -1,553 -1,418 -1,000
Debt-free Net Working Capital (DFNWC)
491 273 254 284 327 229 196 205 463 482 888
Net Working Capital (NWC)
362 138 124 158 -301 108 62 95 360 385 795
Net Nonoperating Expense (NNE)
34 57 4.81 107 -11 115 125 548 35 140 122
Net Nonoperating Obligations (NNO)
1,698 1,911 1,967 1,685 1,567 1,834 1,762 1,359 1,186 1,297 1,312
Total Depreciation and Amortization (D&A)
703 678 621 693 746 759 772 797 777 740 731
Debt-free, Cash-free Net Working Capital to Revenue
-6.72% -6.91% -6.54% -7.91% -8.28% -7.03% -7.83% -9.71% -8.85% -7.97% -5.50%
Debt-free Net Working Capital to Revenue
3.25% 1.78% 1.63% 1.77% 1.99% 1.36% 1.16% 1.20% 2.64% 2.71% 4.88%
Net Working Capital to Revenue
2.40% 0.90% 0.80% 0.98% -1.83% 0.64% 0.37% 0.56% 2.05% 2.16% 4.37%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.93 ($0.19) $0.05 ($0.19) ($0.05) ($0.62) ($0.62) ($3.24) ($0.47) ($1.24) ($1.11)
Adjusted Weighted Average Basic Shares Outstanding
232.20M 231.60M 230.50M 229.20M 229.60M 229.10M 227.90M 226.70M 227M 226.80M 225.30M
Adjusted Diluted Earnings per Share
$0.89 ($0.19) $0.05 ($0.19) ($0.05) ($0.62) ($0.62) ($3.24) ($0.47) ($1.24) ($1.11)
Adjusted Weighted Average Diluted Shares Outstanding
240.70M 231.60M 235.80M 229.20M 229.60M 229.10M 227.90M 226.70M 227M 226.80M 225.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
232.69M 232.27M 231.21M 230.51M 230.10M 229.46M 228.89M 227.84M 227.51M 226.79M 226.76M
Normalized Net Operating Profit after Tax (NOPAT)
126 14 78 21 18 6.30 13 -158 -38 -93 -56
Normalized NOPAT Margin
3.36% 0.37% 2.10% 0.55% 0.46% 0.15% 0.32% -3.70% -0.88% -2.23% -1.31%
Pre Tax Income Margin
6.89% -0.13% 1.71% -0.08% 1.35% -2.68% -2.60% -6.79% -3.21% -5.24% -4.78%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.29 0.80 3.29 0.97 2.06 -0.56 -0.26 -19.29 -2.76 -10.58 -7.63
NOPAT to Interest Expense
6.08 0.56 0.56 0.68 -0.47 -0.39 -0.19 -13.50 -1.93 -7.41 -5.34
EBIT Less CapEx to Interest Expense
5.02 -3.36 -0.21 -1.18 -1.12 -1.44 -1.34 -30.07 -9.11 -23.74 -16.21
NOPAT Less CapEx to Interest Expense
3.81 -3.60 -2.94 -1.48 -3.65 -1.28 -1.27 -24.29 -8.28 -20.56 -13.92
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Kyndryl's Financials

When does Kyndryl's fiscal year end?

According to the most recent income statement we have on file, Kyndryl's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Kyndryl's net income changed over the last 4 years?

Kyndryl's net income appears to be on a downward trend, with a most recent value of -$340 million in 2024, falling from -$943 million in 2019. The previous period was -$1.37 billion in 2023. Check out Kyndryl's forecast to explore projected trends and price targets.

What is Kyndryl's operating income?
Kyndryl's total operating income in 2024 was $91 million, based on the following breakdown:
  • Total Gross Profit: $2.86 billion
  • Total Operating Expenses: $2.77 billion
How has Kyndryl revenue changed over the last 4 years?

Over the last 4 years, Kyndryl's total revenue changed from $20.28 billion in 2019 to $16.05 billion in 2024, a change of -20.8%.

How much debt does Kyndryl have?

Kyndryl's total liabilities were at $9.47 billion at the end of 2024, a 5.3% decrease from 2023, and a 50.9% increase since 2020.

How much cash does Kyndryl have?

In the past 3 years, Kyndryl's cash and equivalents has ranged from $24 million in 2020 to $2.13 billion in 2022, and is currently $1.55 billion as of their latest financial filing in 2024.

How has Kyndryl's book value per share changed over the last 5 years?

Over the last 5 years, Kyndryl's book value per share changed from 0.00 in 2019 to 4.41 in 2024, a change of 441.1%.



This page (NYSE:KD) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners